Georg Lab Well Represented at the International Retinoids Conference
July 29, 2024
Prof. Gunda Georg and her laboratory were major contributors to this year's International Retinoids Conference.
Prof. Georg gave a talk, Discovery of Retinoid Receptor Antagonists for Male Contraception, that highlighted the science behind her development of the first non-hormonal oral male contraceptive.
Graduate students from her lab were also able to make their mark. Rui Shi presented a short talk to the conference in addition to Prof. Georg's, and his peers Noha Taher and Ehfazul Haque were both selected for poster awards.
We are proud of their contributions and always thrilled to have Prof. Georg's expertise in our department.
Find more information about the Georg Group here.
Find more infromation about the International Retinoids Conference here.
Media Contacts
Related Stories
Dr. Melanie Nicol, associate professor and director of graduate studies in the Department of Experimental and Clinical Pharmacology (ECP) received a new award of $3 million across the next five years from the National Institutes of Health (NIH).
Duerfeldt's research is focused on the development of chemical tools that can be utilized to enhance our understanding of disease mechanisms and the development of new therapeutic leads for bacterial infections and ocular diseases.
The Center for Drug Design (CDD), part of the University of Minnesota College of Pharmacy, created a novel technology using biomimetic decoy molecules to boost the skin's natural ability to mitigate ultraviolet-induced damage, a development that has the potential to revolutionize the skincare industry.